|
Therapeutic
(1–5.5 mg/L) |
Subtherapeutic (<1 mg/L) | Supratherapeutic (>5.5 mg/L) | p-Value | |
| Administration route, n (%) | ||||
| Parenteral Oral |
29 (35.6) 16 (64.4) |
7 (50.0) 7 (50.0) |
22 (75.9) 7 (24.1) |
0.235 |
| Adverse effects, n (%) | 0 (0.0) | 0 (0.0) | 4 (13.8) | - |
| median dose/day (mg), (minimum–maximum) | 400 (360–800) | 480 (300–900) | 560 (400–800) | 0.113 |